Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.R600007200 on June 9, 2006

J. Biol. Chem., Vol. 281, Issue 33, 23297-23301, August 18, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
281/33/23297    most recent
R600007200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reinberg, D.
Right arrow Articles by Sims, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reinberg, D.
Right arrow Articles by Sims, R. J., III
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Minireview

de FACTo Nucleosome Dynamics*Formula

Danny Reinberg{ddagger}§1 and Robert J. Sims, III§2

From the {ddagger}Howard Hughes Medical Institute and §Division of Nucleic Acids Enzymology, Department of Biochemistry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854

The factors required for the delivery of RNA polymerase II to class II promoters using naked DNA were all identified by 1998, yet their exact mechanisms of action were not fully understood in all cases, and in some instances, their precise function still remains unknown. Nonetheless, a complete understanding of the complexity of the RNA polymerase II transcription cycle necessitated the development of assays that include chromatinized DNA templates. At this time, the field was actively searching for factors that allow transcription initiation on chromatinized templates. We began studies using chromatin templates in an attempt to identify factor(s) that permit RNA polymerase II to traverse nucleosomes, i.e. that allow elongation on chromatinized DNA templates. The challenge herein was to develop an assay that directly measured the ability of transcriptionally engaged RNA polymerase II to traverse nucleosomes. This approach resulted in the isolation of FACT, a heterodimer in humans comprised of Spt16 and SSRP1. Defined functional biochemical assays corroborated genetic studies in yeast that allowed the elucidation of FACT function in vivo. Collectively, these approaches demonstrate that FACT is a factor that allows RNA polymerase II to traverse nucleosomes in vitro and in vivo by removing one H2A/H2B dimer. More recent studies using a fully defined chromatin reconstitution/transcription assay revealed that FACT activity is greatly stimulated by post-translational modification of the histone polypeptides, specifically by monoubiquitination of lysine 120 of human histone H2B.


* This minireview will be reprinted in the 2006 Minireview Compendium, which will be available in January, 2007. The studies on FACT were supported by National Institutes of Health Grant GM37120 and by the Howard Hughes Medical Institute.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. S1 and supplemental Ref. 1.

2 Supported by National Institutes of Health Grant GM71166.

1 To whom correspondence should be addressed. Tel.: 732-235-4195; Fax: 732-235-5294; E-mail: reinbedf{at}umdnj.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
S. Egloff, H. Al-Rawaf, D. O'Reilly, and S. Murphy
Chromatin Structure Is Implicated in "Late" Elongation Checkpoints on the U2 snRNA and {beta}-Actin Genes
Mol. Cell. Biol., July 15, 2009; 29(14): 4002 - 4013.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Rodriguez-Paredes, M. Ceballos-Chavez, M. Esteller, M. Garcia-Dominguez, and J. C. Reyes
The chromatin remodeling factor CHD8 interacts with elongating RNA polymerase II and controls expression of the cyclin E2 gene
Nucleic Acids Res., May 1, 2009; 37(8): 2449 - 2460.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Dejmek, J. D. Iglehart, and J.-B. Lazaro
DNA-Dependent Protein Kinase (DNA-PK)-Dependent Cisplatin-Induced Loss of Nucleolar Facilitator of Chromatin Transcription (FACT) and Regulation of Cisplatin Sensitivity by DNA-PK and FACT
Mol. Cancer Res., April 1, 2009; 7(4): 581 - 591.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Stuwe, M. Hothorn, E. Lejeune, V. Rybin, M. Bortfeld, K. Scheffzek, and A. G. Ladurner
The FACT Spt16 "peptidase" domain is a histone H3-H4 binding module
PNAS, July 1, 2008; 105(26): 8884 - 8889.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. C. Del Rosario and L. F. Pemberton
Nap1 Links Transcription Elongation, Chromatin Assembly, and Messenger RNP Complex Biogenesis
Mol. Cell. Biol., April 1, 2008; 28(7): 2113 - 2124.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. VanDemark, H. Xin, L. McCullough, R. Rawlins, S. Bentley, A. Heroux, D. J. Stillman, C. P. Hill, and T. Formosa
Structural and Functional Analysis of the Spt16p N-terminal Domain Reveals Overlapping Roles of yFACT Subunits
J. Biol. Chem., February 22, 2008; 283(8): 5058 - 5068.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
F. Zahir, H. V Firth, A. Baross, A. D Delaney, P. Eydoux, W. T Gibson, S. Langlois, H. Martin, L. Willatt, M. A Marra, et al.
Novel deletions of 14q11.2 associated with developmental delay, cognitive impairment and similar minor anomalies in three children
J. Med. Genet., September 1, 2007; 44(9): 556 - 561.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
A. A. Duina, A. Rufiange, J. Bracey, J. Hall, A. Nourani, and F. Winston
Evidence that the Localization of the Elongation Factor Spt16 Across Transcribed Genes Is Dependent Upon Histone H3 Integrity in Saccharomyces cerevisiae
Genetics, September 1, 2007; 177(1): 101 - 112.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. Zlatanova, C. Seebart, and M. Tomschik
Nap1: taking a closer look at a juggler protein of extraordinary skills
FASEB J, May 1, 2007; 21(7): 1294 - 1310.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
R. N. Laribee, S. M. Fuchs, and B. D. Strahl
H2B ubiquitylation in transcriptional control: a FACT-finding mission
Genes & Dev., April 1, 2007; 21(7): 737 - 743.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Li, S. X. Zeng, I. Landais, and H. Lu
Human SSRP1 Has Spt16-dependent and -independent Roles in Gene Transcription
J. Biol. Chem., March 9, 2007; 282(10): 6936 - 6945.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S. M. Yoh, H. Cho, L. Pickle, R. M. Evans, and K. A. Jones
The Spt6 SH2 domain binds Ser2-P RNAPII to direct Iws1-dependent mRNA splicing and export
Genes & Dev., January 15, 2007; 21(2): 160 - 174.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement